Multiple Sclerosis Primary Progressive Clinical Trials

ReadTheTrial indexes 2 studies for Multiple Sclerosis Primary Progressive. The most common development stage is N/A (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Multiple Sclerosis Primary Progressive.

Pipeline by Phase

PhaseTrialsDistribution
N/A 1
50%
Phase 3 1
50%

Trial Status Breakdown

Trials for Multiple Sclerosis Primary Progressive

Motor Asymmetry in Progressive Multiple Sclerosis Patients

NCT04918225 · COMPLETED · N/A

A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients With Primary Progressive Multiple Sclerosis.

NCT04544449 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Multiple Sclerosis Primary Progressive?

There are 2 clinical trials listed for Multiple Sclerosis Primary Progressive. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Multiple Sclerosis Primary Progressive trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Multiple Sclerosis Primary Progressive trials in?

Current Multiple Sclerosis Primary Progressive trials are distributed across: N/A (1), Phase 3 (1).

Find More Trials